# Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis

> **NCT01745783** · PHASE1,PHASE2 · COMPLETED · sponsor: **Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud** · enrollment: 26 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **OTHER:** Bone marrow mesenchymal stem cells autologous
- **OTHER:** Placebo comparator

## Key facts

- **NCT ID:** NCT01745783
- **Lead sponsor:** Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2020-06-30
- **Final completion:** 2020-06-30
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2022-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01745783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01745783, "Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple Sclerosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01745783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*